Summary of characteristics, as well as number of deaths and number lost to follow-up, between HIV-positive and HIV-negative participants at PREVAIL I and PREVAIL III baseline.
posted on 2021-09-10, 17:39authored bySoka J. Moses, Ian Wachekwa, Collin Van Ryn, Greg Grandits, Alice Pau, Moses Badio, Stephen B. Kennedy, Michael C. Sneller, Elizabeth S. Higgs, H. Clifford Lane, Mosoka Fallah, Stephen A. Migueles, Cavan Reilly
Summary of characteristics, as well as number of deaths and number lost to follow-up, between HIV-positive and HIV-negative participants at PREVAIL I and PREVAIL III baseline.